VetiVax is a series of subcutaneous injections that works by recognizing the animal’s own tumor cells and activating the immune system to fight the cancer.
Bacteria and viruses contain antigens on their surface that allow the immune system to identify those pathogens and mount a response to destroy them. Cancer cells also contain antigens on their surface, but they pass by the immune surveillance system and continue growing. By creating an immunotherapy utilizing the animal’s own deactivated tumor cells we can tell the immune system that these cells are foreign and must be destroyed.
This method of using immunotherapy as a way to fight cancer encompasses decades of research, and VetiVax is a safe and effective route for antigen presentation. VetiVax has been administered with limited clinically observed negative side effects (lethargy, slight fever and localized injection site pain and redness) in clinics nationwide.
If you have a client pet that you think could be a candidate for VetiVax, please click the following link: Is VetiVax Right for My Pet?
Clinical Trial Registry
Torigen is currently recruiting veterinarian candidates to participate in a cancer clinical trial registry. Please contact Ashley Kalinauskas for more details: (860)519-9956 or A.Kalinauskas@vetivax.com